MICARDIS® (telmisartan) is a powerful angiotensin II receptor blocker (ARB) that offers, consistent, 24-hour, blood pressure control,1-3 even in the early morning hours when the risk of cardiovascular events is at its highest.4-6
MICARDIS® provides superior blood pressure reduction compared to the ARBs valsartan and losartan2,3,7 and has been shown to achieve blood pressure targets at least as effectively as other antihypertensive classes, including the ACE inhibitors enalapril, 8 ramipril 9,10 and lisinopril,11 the calcium channel blocker amlodipine1 or the beta-blocker atenolol.12 Importantly, MICARDIS® has been shown to have placebo-like tolerability.13
Data suggest that MICARDIS® may have additional cardioprotective properties beyond blood pressure reduction, including a proven ability to reduce left ventricular hypertrophy.14,15 Further additional cardioprotective properties of MICARDIS® are being investigated in more than 50,000 patients, and the results of ongoing clinical studies are expected to usher in a new era in cardiovascular protection.16-18
On this website you can find out all about MICARDIS® and MICARDISPLUS® (telmisartan/hydrochlorothiazide). MICARDISPLUS® is available for those patients who may need additional blood pressure control.19-21
Calendar
Tools and Downloads
- Events Calendar
- Free ONTARGET® Online Publication Download
- Hypertension Treatment Guidelines
- MICARDIS® / MICARDISPLUS® Product Monograph
- ONTARGET® Results Webcast
- Renin Angiotensin System in Cardiovascular Medicine Journal
My Alerts
You will shortly be able to create your own personal alerts service bringing the latest MICARDIS® news and updates direct to your inbox. Watch this space for more information.